Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age

Simple item page
dc.contributor.authorKnuf, M.
dc.contributor.authorLeroux-Roels, G.
dc.contributor.authorRumke, H.
dc.contributor.authorAbarca Villaseca, Katia
dc.contributor.authorRivera, L.
dc.contributor.authorLattanzi, M.
dc.contributor.authorPedotti, P.
dc.contributor.authorArora, A.
dc.date.accessioned2020-10-02T00:43:43Z
dc.date.available2020-10-02T00:43:43Z
dc.date.issued2014
dc.fuente.origenConveris
dc.identifier.doi10.1097/INF.0000000000000462
dc.identifier.issn0891-3668
dc.identifier.urihttps://doi.org/10.1097/INF.0000000000000462
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/46539
dc.issue.numeroNo. 12
dc.language.isoen
dc.pagina.finalE329
dc.pagina.inicioE320
dc.revistaPediatric Infectious Disease Journales_ES
dc.rightsacceso restringido
dc.titleImmunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Agees_ES
dc.typeartículo
dc.volumenVol. 33
sipa.codpersvinculados70281
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A:H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age.pdf
Size:
348.02 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas